NO20074505L - Partikkel og preparat inneholdende partikkelen - Google Patents

Partikkel og preparat inneholdende partikkelen

Info

Publication number
NO20074505L
NO20074505L NO20074505A NO20074505A NO20074505L NO 20074505 L NO20074505 L NO 20074505L NO 20074505 A NO20074505 A NO 20074505A NO 20074505 A NO20074505 A NO 20074505A NO 20074505 L NO20074505 L NO 20074505L
Authority
NO
Norway
Prior art keywords
particle
particles
preparation containing
amino
benzylpiperidin
Prior art date
Application number
NO20074505A
Other languages
English (en)
Norwegian (no)
Inventor
Hideo Masuda
Hikaru Sugihara
Akio Nashiura
Kazuyuki Hayashi
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of NO20074505L publication Critical patent/NO20074505L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20074505A 2005-03-09 2007-09-05 Partikkel og preparat inneholdende partikkelen NO20074505L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005066158 2005-03-09
PCT/JP2006/304506 WO2006095788A1 (ja) 2005-03-09 2006-03-08 粒子およびその粒子を含有する製剤

Publications (1)

Publication Number Publication Date
NO20074505L true NO20074505L (no) 2007-12-10

Family

ID=36953382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074505A NO20074505L (no) 2005-03-09 2007-09-05 Partikkel og preparat inneholdende partikkelen

Country Status (13)

Country Link
US (1) US20090022915A1 (ja)
EP (1) EP1857114A1 (ja)
JP (1) JPWO2006095788A1 (ja)
KR (1) KR20070110418A (ja)
CN (1) CN101171023A (ja)
AU (1) AU2006221364A1 (ja)
BR (1) BRPI0608844A2 (ja)
CA (1) CA2602007A1 (ja)
IL (1) IL185590A0 (ja)
NO (1) NO20074505L (ja)
RU (1) RU2007137121A (ja)
WO (1) WO2006095788A1 (ja)
ZA (1) ZA200707436B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5550546B2 (ja) * 2007-04-13 2014-07-16 ケムジェネックス・ファーマシューティカルズ・インコーポレイテッド 経口セファロタキシン剤形
WO2009047935A1 (ja) * 2007-10-12 2009-04-16 Ono Pharmaceutical Co., Ltd. 微粒子

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2764274B2 (ja) * 1988-03-28 1998-06-11 株式会社ミドリ十字 医薬組成物
JPH07291854A (ja) * 1994-04-26 1995-11-07 Tanabe Seiyaku Co Ltd 溶解性の改善された医薬品製剤
MA25590A1 (fr) * 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
AU2001266392A1 (en) * 2000-06-27 2002-01-08 Mi Tech Company Limited The controlled release preparation of insulin and its method
AU2003218306B2 (en) * 2002-03-20 2006-09-14 Advanced Inhalation Research, Inc. Method for administration of growth hormone via pulmonary delivery
DK2630954T3 (en) * 2002-03-20 2017-01-23 Civitas Therapeutics Inc PULMONAL SUBMISSION OF LEVODOPA
JP2004175795A (ja) * 2002-11-13 2004-06-24 Takeda Chem Ind Ltd 薬物の放出性に優れた医薬組成物
CN101371843B (zh) * 2002-11-26 2012-09-26 艾利斯达医药品公司 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
WO2004113332A1 (ja) * 2003-06-19 2004-12-29 Ono Pharmaceutical Co., Ltd. 経鼻製剤

Also Published As

Publication number Publication date
CA2602007A1 (en) 2006-09-14
CN101171023A (zh) 2008-04-30
BRPI0608844A2 (pt) 2010-02-02
AU2006221364A1 (en) 2006-09-14
EP1857114A1 (en) 2007-11-21
KR20070110418A (ko) 2007-11-16
IL185590A0 (en) 2008-01-06
RU2007137121A (ru) 2009-04-20
JPWO2006095788A1 (ja) 2008-08-14
ZA200707436B (en) 2009-08-26
US20090022915A1 (en) 2009-01-22
WO2006095788A1 (ja) 2006-09-14

Similar Documents

Publication Publication Date Title
WO2008021927A3 (en) Hepatitis c virus inhibitors
MX2008002484A (es) Formulaciones de acetato de bazedoxifeno y proceso de fabricacion de los mismos.
WO2006029233A3 (en) Apparatus for prolonging survival of platelets
WO2008021936A3 (en) Hepatitis c virus inhibitors
TW200606149A (en) Crystalline polymorph of bazedoxifene acetate
WO2007047687A3 (en) Compositions and methods for prolonging survival of platelets
WO2008061243A3 (en) Respiratory syncytial virus-virus like particle (vlps)
WO2007041156A3 (en) Antibiotic formulations, unit doses, kits, and methods
UA86055C2 (ru) Кристаллическая форма в базедоксифена ацетата
BRPI0719393B8 (pt) composição farmacêutica
WO2006048750A3 (en) Novel compounds of substituted and unsubstituted adamantyl amides
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
NZ592383A (en) Pharmaceutical composition of a potent hcv inhibitor for oral administration
MX2009004767A (es) Preparacion liquida que comprende un complejo de pimobendan y ciclodextrina.
EP1812014A4 (en) COMPOSITIONS AND METHODS FOR EXTENDING THE SURVIVAL OF BLOODPLATES
NO20083535L (no) Alfa-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette
WO2007117591A3 (en) Total synthesis of salinosporamide a and analogs thereof
WO2008002662A3 (en) Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells
WO2008107502A8 (es) Composicion para el tratamiento de enfermedades infecciosas
WO2008033888A3 (en) Methods for administering long-lasting hypoglycemic agents
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
NZ603108A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
WO2009027452A3 (en) Radiopharmaceutical composition
NO20074505L (no) Partikkel og preparat inneholdende partikkelen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application